Medications in pregnancy and lactation: Part 2. drugs with minimal or unknown human teratogenic effect

Obstetrics and Gynecology

Volumn 113, Issue 2 PART 1, 2009, Pages 417-432

  Buhimschi, Catalin S ^a   Weiner, Carl P ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ACICLOVIR; ALAXAN; ARTESUNATE; ATROPINE; AZITHROMYCIN; BETAMETHASONE; CETIRIZINE; CIPROFLOXACIN; CLINDAMYCIN; DEXTROPROPOXYPHENE; DIMENHYDRINATE; DIPHENHYDRAMINE; DOXYCYCLINE; ERYTHROMYCIN; HYDRALAZINE; IBUPROFEN; LABETALOL; METHYLDOPA; METRONIDAZOLE; NAPROXEN; NITROFURANTOIN; OXYTETRACYCLINE; PARACETAMOL; PENICILLIN G; PREDNISOLONE; PREDNISONE; PROPRANOLOL; SALBUTAMOL; TETRACHLOROETHYLENE; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; PRESCRIPTION DRUG;

ABSENCE OF SIDE EFFECTS; ACTINOMYCOSIS; ACUTE DISEASE; ALLERGIC RHINITIS; ANTHRAX; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; ASTHMA; BACTERIURIA; BLEEDING; BRADYCARDIA; CARDIOVASCULAR DISEASE; CHLAMYDIASIS; CHORIOAMNIONITIS; CHRONIC DISEASE; CLEFT PALATE; CLOSTRIDIUM DIFFICILE INFECTION; CLUBFOOT; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DRUG ABSORPTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG SAFETY; ENDOMYOMETRITIS; ENTERITIS; FETUS DEATH; FETUS DISEASE; FINGER MALFORMATION; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; GASTROSCHISIS; GENITAL HERPES; GONORRHEA; HEADACHE; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERTHERMIA; HYPOGLYCEMIA; HYPOPROTHROMBINEMIA; HYPOTENSION; INCIDENCE; INFECTION; INTESTINE ATRESIA; INTOXICATION; INTRAUTERINE GROWTH RETARDATION; IRRITABILITY; LACTATION; LETHARGY; LISTERIOSIS; LIVER DYSFUNCTION; MALARIA; MATERNAL AGE; MATERNAL CARE; MATERNAL HYPERTENSION; MEDICAL SPECIALIST; MICROCEPHALY; MIGRAINE; NAUSEA AND VOMITING; NEPHROTOXICITY; NEURAL TUBE DEFECT; NEWBORN DISEASE; PAIN; PERICARDIAL EFFUSION; PHEOCHROMOCYTOMA; POSTOPERATIVE PAIN; POSTPARTUM PAIN; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRESCRIPTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; Q FEVER; RECURRENT INFECTION; REVIEW; RHEUMATIC FEVER; RISK FACTOR; SIDE EFFECT; SPONTANEOUS ABORTION; SYPHILIS; TACHYPNEA; TERATOGENESIS; THROMBOSIS; THYROTOXICOSIS; TOOTH DISCOLORATION; TREATMENT INDICATION; TUBERCULOSIS; UREAPLASMA INFECTION; URINARY TRACT INFECTION; VAGINITIS; VASCULAR DISEASE; VINCENT STOMATITIS; DRUG TOXICITY; FEMALE; FETOMATERNAL TRANSFUSION;

DRUG TOXICITY; FEMALE; HUMANS; LACTATION; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRESCRIPTION DRUGS;

EID: 60549090457     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31818d686c     Document Type: Review

References (124)

1. Li DK, Liu L, Odouli R. Exposure to non-steroidal antiinflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368.
2. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation. In: Queenan JT, Spong CY, Lockwood CJ, editors. Management of high-risk pregnancy: an evidence-based approach. 5th ed. Malden (MA): Blackwell Publishing Ltd; 2007. p. 38-58.
3. Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007;42:3-27.
4. Everson GW, Krenzelok EP. Chronic salicylism in a patient with juvenile rheumatoid arthritis. Clin Pharm 1986;5: 334-41.
5. Kozer E, Costei AM, Boskovic R, Nulman I, Nikfar S, Koren G. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res B Dev Reprod Toxicol 2003;68:70-84.
6. James AH, Brancazio LR, Price T. Aspirin and reproductive outcomes. Obstet Gynecol Surv 2008;63:49-57.
7. Nadar S, Blann AD, Lip GY. Effects of aspirin on intraplatelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. Am J Hypertens 2006;19:970-7.
8. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002;99:135-44.
9. Di Nisio M, Peters L, Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD004734. DOI: 10.1002/14651858.CD004734.
10. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment [published erratum appears in Obstet Gynecol 2002;100:1361]. Obstet Gynecol 2002;100:408-13.
11. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701-5.
12. Vainio M, Kujansuu E, Iso-Mustajarvi M, Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002;109:161-7.
13. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007;369:1791-8.
14. Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 1997;56:241-3.
15. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187:1623-30.
16. Bar-Oz B, Bulkowstein M, Benyamini L, Greenberg R, Soriano I, Zimmerman D, et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf 2003;26:925-35.
17. Bleyer WA, Breckenridge RT. Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA 1970;213: 2049-53.
18. Spigset O, Hagg S. Analgesics and breast-feeding: safety considerations. Paediatr Drugs 2000;2:223-38.
19. Acetylcysteine (Acetadote) for acetaminophen overdosage. Med Lett Drugs Ther 2005;47:70-1.
20. Kirshon B, Moise KJ Jr, Wasserstrum N. Effect of acetaminophen on fetal acid-base balance in chorioamnionitis. J Reprod Med 1989;34:955-9.
21. Golden NL, King KC, Sokol RJ. Propoxyphene and acetaminophen. Possible effects on the fetus. Clin Pediatr (Phila) 1982;21:752-4.
22. Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol 2008;82:155-65.
23. Collins E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981;58 suppl: 57S-62S.
24. Sunshine A, Olson NZ, O'Neill E, Ramos I, Doyle R. Analgesic efficacy of a hydrocodone with ibuprofen combination compared with ibuprofen alone for the treatment of acute postoperative pain. J Clin Pharmacol 1997;37:908-15.
25. Wiebe ER, Rawling M. Pain control in abortion. Int J Gynaecol Obstet 1995;50:41-6.
26. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135-40.
27. Watson-Jones D, Gumodoka B, Weiss H, Changalucha J, Todd J, Mugeye K, et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis 2002;186: 948-57.
28. Michelow IC, Wendel GD Jr, Norgard MV, Zeray F, Leos NK, Alsaadi R, et al. Central nervous system infection in congenital syphilis. N Engl J Med 2002;346:1792-8.
29. Ballard RC, Berman SM, Fenton KA. Azithromycin versus penicillin for early syphilis. N Engl J Med 2006;354:203-5.
30. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
31. Pacifici GM. Placental transfer of antibiotics administered to the mother: a review. Int J Clin Pharmacol Ther 2006;44: 57-63.
32. Elek E, Ivan E, Arr M. Passage of penicillins from mother to foetus in humans. Int J Clin Pharmacol 1972;6:223-8.
33. Dashe JS, Gilstrap LC 3rd. Antibiotic use in pregnancy. Obstet Gynecol Clin North Am 1997;24:617-29.
34. Nau H. Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins. Dev Pharmacol Ther 1987;10:174-98.
35. Matheson I, Samseth M, Sande HA. Ampicillin in breast milk during puerperal infections. Eur J Clin Pharmacol 1988;34: 657-9.
36. Stauffer UG. Tooth changes caused by tetracycline in the fetus, infant and child [in German]. Schweiz Med Wochenschr 1967;97:291-3.
37. ElTabbakh GH, Elejalde BR, Broekhuizen FF. Primary syphilis and nonimmune fetal hydrops in a penicillin-allergic woman. A case report. J Reprod Med 1994;39:412-4.
38. Smith JR, Taylor-Robinson D. Infection due to Chlamydia trachomatis in pregnancy and the newborn. Baillieres Clin Obstet Gynaecol 1993;7:237-55.
39. Sexually transmitted diseases in adolescents. ACOG Committee Opinion No. 301. American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Obstet Gynecol 2004;104:891-8.
40. McGregor JA, French JI. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000;55 suppl:S1-19.
41. Klastersky-Genot MT. Effects of tetracycline, administered during pregnancy, on the deciduous teeth. A double blind controlled study [in French]. Acta Stomatol Belg 1970;67: 107-24.
42. Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol 1997;89:524-8.
43. Hendeles L, Trask PA. Tetracycline and lactation. J Am Dent Assoc 1983;107:12, 14.
44. Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001;24:553-65.
45. Centers for Disease Control and Prevention (CDC). Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. MMWR Morb Mortal Wkly Rep 2001;50:960.
46. Ludlam H, Wreghitt TG, Thornton S, Thomson BJ, Bishop NJ, Coomber S, et al. Q fever in pregnancy. J Infect 1997; 34:75-8.
47. Polachek H, Holcberg G, Sapir G, Tsadkin-Tamir M, Polachek J, Katz M, et al. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 2005;122:61-5.
48. Casey B, Bawdon RE. Ex vivo human placental transfer of trovafloxacin. Infect Dis Obstet Gynecol 2000;8:228-9.
49. Peled Y, Friedman S, Hod M, Merlob P. Ofloxacin during the second trimester of pregnancy. DICP 1991;25:1181-2.
50. Giamarellou H, Kolokythas E, Petrikkos G, Gazis J, Aravanti-nos D, Sfikakis P. Pharmacokinetics of three newer quino-lones in pregnant and lactating women. Am J Med 1989;87: 49S-51S.
51. Harmon T, Burkhart G, Applebaum H. Perforated pseudomembranous colitis in the breast-fed infant. J Pediatr Surg 1992;27:744-6.
52. Connell W, Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy [published erratum appears in Drug Saf 1999;21:456]. Drug Saf 1999;21: 311-23.
53. Gulmezoglu AM. Interventions for trichomoniasis in pregnancy. The Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD000220. DOI: 10.1002/14651858.CD000220.
54. Klebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 2004;190:363-70.
55. Klebanoff MA, Hillier SL, Nugent RP, MacPherson CA, Hauth JC, Carey JC et al. Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol 2005;192:470-7.
56. Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005;105:857-68.
57. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
58. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-40.
59. Goldenberg RL, Klebanoff M, Carey JC, Macpherson C. Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynecol 2001;185:485-6.
60. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
61. Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 2006; 113:65-74.
62. Heisterberg L. Placental transfer of metronidazole in the first trimester of pregnancy. J Perinat Med 1984;12:43-5.
63. Passmore CM, McElnay JC, Rainey EA, D'Arcy PF. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988;26:45-51.
64. Wendel PJ, Ramin SM, Barnett-Hamm C, Rowe TF, Cunningham FG. Asthma treatment in pregnancy: a randomized controlled study. Am J Obstet Gynecol 1996;175:150-4.
65. Pongrojpaw D, Somprasit C, Chanthasenanont A. A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy. J Med Assoc Thai 2007;90:1703-9.
66. Aubé M. Migraine in pregnancy. Neurology 1999;53:S26-8.
67. Hay TB, Wood C. The effect of dimenhydrinate on uterine contractions. Aust N Z J Obstet Gynaecol 1967;7:81-9.
68. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, et al. Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf 2008;17: 240-7.
69. Chronic hypertension in pregnancy. ACOG Practice Bulletin. American College of Obstetricians and Gynecologists. Obstet Gynecol 2001;98 suppl: 177-85.
70. Borghi C, Esposti DD, Cassani A, Immordino V, Bovicelli L, Ambrosioni E. The treatment of hypertension in pregnancy. J Hypertens Suppl 2002;20:S52-6.
71. Kirsten R, Nelson K, Kirsten D, Heintz B. Clinical pharma-cokinetics of vasodilators. Part II. Clin Pharmacokinet 1998; 35:9-36.
72. Livingstone I, Craswell PW, Bevan EB, Smith MT, Eadie MJ. Propranolol in pregnancy three year prospective study. Clin Exp Hypertens B 1983;2:341-50.
73. Elhassan EM, Mirghani OA, Habour AB, Adam I. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J 2002;79:172-5.
74. Gunenc O, Cicek N, Gorkemli H, Celik C, Acar A, Akyurek C. The effect of methyldopa treatment on uterine, umbilical and fetal middle cerebral artery blood flows in preeclamptic patients. Arch Gynecol Obstet 2002;266:141-4.
75. Houlihan DD, Dennedy MC, Ravikumar N, Morrison JJ. Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance. J Perinat Med 2004;32: 315-9.
76. Beardmore KS, Morris JM, Gallery ED. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy 2002;21:85-95.
77. Munshi UK, Deorari AK, Paul VK, Singh M. Effects of maternal labetalol on the newborn infant. Indian Pediatr 1992;29:1507-12.
78. Scardo JA, Vermillion ST, Newman RB, Chauhan SP, Hogg BB. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies. Am J Obstet Gynecol 1999;181:862-6.
79. Hennessy A, Thornton CE, Makris A, Ogle RF, Henderson-Smart DJ, Gillin AG, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. Aust N Z J Obstet Gynaecol 2007;47:279-85.
80. Vigil-De Gracia P, Ruiz E, López JC, de Jaramillo IA, Vega-Maleck JC, Pinzón J. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertens Pregnancy 2007;26:163-71.
81. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. The Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001449. DOI: 10.1002/14651858.CD001449.
82. Olsen KS, Beier-Holgersen R. Fetal death following labetalol administration in pre-eclampsia. Acta Obstet Gynecol Scand 1992;71:145-7.
83. Crooks BN, Deshpande SA, Hall C, Platt MP, Milligan DW. Adverse neonatal effects of maternal labetalol treatment. Arch Dis Child Fetal Neonatal Ed 1998;79:F150-1.
84. Hjertberg R, Faxelius G, Belfrage P. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants. Acta Obstet Gynecol Scand 1993;72:611-5.
85. Bowman ML, Bergmann M, Smith JF. Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. Thyroid 1998;8:795-6.
86. Caswell HT, Marks AD, Channick BJ. Propranolol for the preoperative preparation of patients with thyrotoxicosis. Surg Gynecol Obstet 1978;146:908-10.
87. Sukenik S, Biale Y, Ben-Aderet N, Khodadadi J, Levi D, Stern J. Successful control of pheochromocytoma in pregnancy. Case report. Eur J Obstet Gynecol Reprod Biol 1979;9: 249-51.
88. Bott-Kanner G, Schweitzer A, Reisner SH, Joel-Cohen SJ, Rosenfeld JB. Propranolol and hydralazine in the management of essential hypertension in pregnancy. Br J Obstet Gynecol 1980;87:110-4.
89. Reichmuth D, Lockey RF. Present and potential therapy for allergic rhinitis: a review. BioDrugs 2000;14:371-87.
90. Chanda M, Mackenzie P, Day JH. Hypersensitivity reactions following laminaria placement. Contraception 2000;62: 105-6.
91. Stafford CT, Lobel SA, Fruge BC, Moffitt JE, Hoff RG, Fadel HE. Anaphylaxis to human serum albumin. Ann Allergy 1988;61:85-8.
92. Management of herpes in pregnancy. ACOG Practice Bulletin No. 82. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:1489-98.
93. Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 2002; 10:71-7.
94. Little SE, Caughey AB. Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis. Am J Obstet Gynecol 2005;193: 1274-9.
95. Kimberlin DF, Weller S, Whitley RJ, Andrews WW, Hauth JC, Lakeman F, et al. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 1998;179:846-51.
96. Laerum OD. Toxicology of acyclovir. Scand J Infect Dis Suppl 1985;47:40-3.
97. Sheffield JS, Fish DN, Hollier LM, Cadematori S, Nobles BJ, Wendel GD Jr. Acyclovir concentrations in human breast milk after valacyclovir administration. Am J Obstet Gynecol 2002;186:100-2.
98. Egerman RS, Mercer BM, Doss JL, Sibai BM. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Am J Obstet Gynecol 1998;179:1120-3.
99. Gurbuz A, Karateke A, Ozturk G, Kabaca C. Is 1-hour glucose screening test reliable after a short-term administration of antenatal betamethasone? Am J Perinatol 2004;21: 415-20.
100. Elliott JP, O'Keeffe DF, Greenberg P, Freeman RK. Pulmonary edema associated with magnesium sulfate and betamethasone administration. Am J Obstet Gynecol 1979;134: 717-9.
101. Mushkat Y, Ascher-Landsberg J, Keidar R, Carmon E, Pauzner D, David MP. The effect of betamethasone versus dexamethasone on fetal biophysical parameters. Eur J Obstet Gynecol Reprod Biol 2001;97:50-2.
102. Lockshin MD, Sammaritano LR. Corticosteroids during pregnancy. Scand J Rheumatol Suppl 1998;107:136-8.
103. Walker BE. Induction of cleft palate in rats with antiinflammatory drugs. Teratology 1971;4:39-42.
104. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92.
105. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007;197:585.e1-7.
106. Spinillo A, Viazzo F, Colleoni R, Chiara A, Maria Cerbo R, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004;191:217-24.
107. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. Repeated prenatal corticosteroid administration delays myeli- nation of the corpus callosum in fetal sheep. Int J Dev Neurosci 2001;19:415-25.
108. Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 2000;83: F154-7.
109. Hayes EJ, Paul DA, Stahl GE, Seibel-Seamon J, Dysart K, Leiby BE, et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol 2008;111:921-6.
110. Antenatal corticosteroid therapy for fetal maturation. ACOG Committee Opinion. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Obstet Gynecol 2002;99:871-3.
111. Wapner RJ, Sorokin Y, Thom EA, Johnson F, Dudley DJ, Spong CY, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006;195:633-42.
112. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169:1411-7.
113. Addison RS, Maguire DJ, Mortimer RH, Cannell GR. Metabolism of prednisolone by the isolated perfused human placental lobule. J Steroid Biochem Mol Biol 1991;39:83-90.
114. Lieman JM, Brumfield CG, Carlo W, Ramsey PS. Preterm premature rupture of membranes: is there an optimal gestational age for delivery? Obstet Gynecol 2005;105:12-7.
115. Walfisch A, Hallak M, Mazor M. Multiple courses of antenatal steroids: risks and benefits. Obstet Gynecol 2001;98:491-7.
116. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994;12:1-24.
117. Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol 1997;104:1239-47.
118. Fujii Y, Uemura A. Dexamethasone for the prevention of nausea and vomiting after dilatation and curettage: a randomized controlled trial. Obstet Gynecol 2002;99:58-62.
119. Martin JN Jr, Thigpen BD, Rose CH, Cushman J, Moore A, May WL. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 2003;189:830-4.
120. Fonseca JE, Mendez F, Catano C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2005;193: 1591-8.
121. Costedoat-Chalumeau N, Georgin-Lavialle S, Amoura Z, Piette JC. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus 2005;14:660-4.
122. Rotmensch S, Lev S, Kovo M, Efrat Z, Zahavi Z, Lev N, et al. Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study. Fetal Diagn Ther 2005; 20:371-6.
123. Hughes I. Prenatal treatment of congenital adrenal hyperplasia: do we have enough evidence? Treat Endocrinol 2006;5:1-6.
124. Brook CG. Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia. Arch Dis Child Fetal Neonatal Ed 2000;82:F176-81.